156 related articles for article (PubMed ID: 19073523)
1. At long last, it's finally 'T' time.
O'Connor OA
Clin Lymphoma Myeloma; 2008 Dec; 8 Suppl 5():S166-7. PubMed ID: 19073523
[No Abstract] [Full Text] [Related]
2. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma: a diagnostic and therapeutic challenge.
Nofal A; Abdel-Mawla MY; Assaf M; Salah E; Abd-Elazim H
Int J Dermatol; 2014 Jan; 53(1):76-81. PubMed ID: 23786415
[No Abstract] [Full Text] [Related]
3. [Granulomatous slack skin with anaplastic large cell lymphoma: report of a case].
Xie JJ; Zhou ZQ; Wang Y; Li Y; Zhang RY; Ren YB; Chen B; Zhou GY
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):267-8. PubMed ID: 21616005
[No Abstract] [Full Text] [Related]
4. Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
Kost Al M; Kost Alová M; Belada D; Laco J
Int J Dermatol; 2009 Dec; 48(12):1338-42. PubMed ID: 19930492
[No Abstract] [Full Text] [Related]
5. An unusual ulcer in an 8-year-old girl.
Friedman A; Abadi M; Wu K; Fisher M; Abadi J
Dermatol Online J; 2010 Feb; 16(2):6. PubMed ID: 20178702
[No Abstract] [Full Text] [Related]
6. New concepts in treatment approaches and prognostic factors in aggressive NHL.
Shipp M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
[No Abstract] [Full Text] [Related]
7. Destructive midline palatal lesion.
Loudon JA; Marsh WL; Allen CM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):134-6. PubMed ID: 10673645
[No Abstract] [Full Text] [Related]
8. Subcutaneous T-cell lymphoma.
Nguyen NQ
Dermatol Online J; 2003 Oct; 9(4):42. PubMed ID: 14594615
[TBL] [Abstract][Full Text] [Related]
9. CHOP plus rituximab--balancing facts and opinion.
Cheson BD
N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154
[No Abstract] [Full Text] [Related]
10. Leukaemic presentation of angioimmunoblastic T-cell lymphoma.
Lin KW; Lee YS; Phipps C
Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735
[No Abstract] [Full Text] [Related]
11. [Analytical study of 13 cases of cutaneous lymphoma].
Kort R; Mokni M; Rouatbi M; Azaiz MI; Kchir N; Haouet S; Boubaker S; Zitouna M; Ben Osman A
Tunis Med; 1995; 73(6-7):247-52. PubMed ID: 9506173
[No Abstract] [Full Text] [Related]
12. Update in T-cell lymphoma.
O'Connor OA
Clin Adv Hematol Oncol; 2010 Sep; 8(9):604-6. PubMed ID: 21157409
[No Abstract] [Full Text] [Related]
13. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
[No Abstract] [Full Text] [Related]
14. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
[No Abstract] [Full Text] [Related]
15. T-cell lymphoma presenting as a rapidly enlarging tumor on the lower eyelid.
Onesti MG; Mazzocchi M; De Leo A; Scuderi N
Acta Chir Plast; 2005; 47(3):65-6. PubMed ID: 16173513
[TBL] [Abstract][Full Text] [Related]
16. Intravascular cytotoxic T-cell lymphoma: A case report and review of the literature.
Gleason BC; Brinster NK; Granter SR; Pinkus GS; Lindeman NI; Miller DM
J Am Acad Dermatol; 2008 Feb; 58(2):290-4. PubMed ID: 18222325
[TBL] [Abstract][Full Text] [Related]
17. Thoracic subcutaneous infiltration: an unusual presentation of subcutaneous panniculitis-like T-cell lymphoma.
Ballanger F; Barbarot S; Le Gouill S; Gaillard F; Cassagnau E; Lodé L; Dréno B; Stalder JF
Acta Derm Venereol; 2009; 89(4):427-9. PubMed ID: 19688166
[No Abstract] [Full Text] [Related]
18. Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
Hosler GA; Liégeois N; Anhalt GJ; Moresi JM
J Cutan Pathol; 2008 Nov; 35(11):1063-7. PubMed ID: 18544066
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.
Takács I; Eros N; Bene I; Bozsó F; Tordai L; Károlyi Z; Radványi G; Matolcsy A
Ann Hematol; 2004 Sep; 83(9):608-10. PubMed ID: 15205915
[No Abstract] [Full Text] [Related]
20. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
